WinstonWınston
Back
Eurofins Scientific SE logo

Eurofins Scientific SE

ERF.PA
53
Medical - Diagnostics & Research · Healthcare
Price
€72.84
+0.02 (+0.03%)
Market Cap
€12.59B
Exchange
Euronext Paris
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Weak

Share count falling — buybacks

6.8% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 200.6M (2021) → 187.0M (2025)

Winston Score History

The full picture

Eurofins Scientific is a company that tests things — food, water, medicine, and the environment — to make sure they are safe and meet legal standards. Its main customers are food companies, pharmaceutical firms, hospitals, and government agencies that need certified lab results. It is one of the largest testing and laboratory services networks in the world, operating thousands of labs across more than 60 countries.

The company makes money by charging fees each time a customer sends in a sample for analysis — think of it like a pay-per-test model. Most of its revenue comes from Europe and North America, and its scale gives it a cost advantage that smaller labs struggle to match. A key risk is that a large chunk of its recent revenue came from COVID-19 testing, which has declined sharply, so the company must replace that lost income by growing its food, pharma, and environmental testing businesses.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.5% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+43.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

36.3%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

€717M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Eurofins Scientific SE is growing revenue at 2% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.5%
Thin — 13.5% gross margin
Profit after running costs
Operating Margin
13.5%
Healthy — 13.5% operating margin
Return on the money invested
ROCE
9.7%
Below par — 9.7% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.4%
Slow sales growth (+3.4% YoY)
Profit growth
EPS YoY
+37.0%
Earnings growing fast (+37.0% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
257%
Turns 257% of profit into real cash
Spare cash per sale
FCF Margin
8.6%
Modest free cash flow (8.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.51
Elevated debt (1.51)
Covers its interest
Interest Cover
4.79x
Adequate interest coverage (4.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
24.3x
Growth-priced — P/E 24.3

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+8.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (24.3 → 15.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.03%
Small dividend — 1.03% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
-59.5%
Dividend cut (-59.5% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial